Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
Takami Sato, Mizue Terai, Yutaka Tamura, et al.
Immunologic Research (2011) Vol. 51, Iss. 2-3, pp. 170-182
Closed Access | Times Cited: 249

Showing 1-25 of 249 citing articles:

Tumor-Associated Macrophages: Recent Insights and Therapies
Jiawei Zhou, Ziwei Tang, Siyang Gao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 532
The paradoxical role of IL-10 in immunity and cancer
Mark H. Mannino, Ziwen Zhu, Huaping Xiao, et al.
Cancer Letters (2015) Vol. 367, Iss. 2, pp. 103-107
Closed Access | Times Cited: 421
M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
Chaoying Liu, Juan-Ying Xu, Xiaoyan Shi, et al.
Laboratory Investigation (2013) Vol. 93, Iss. 7, pp. 844-854
Open Access | Times Cited: 414
When Immune Cells Turn Bad—Tumor-Associated Microglia/Macrophages in Glioma
Saskia Roesch, Carmen Rapp, Steffen Dettling, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 436-436
Open Access | Times Cited: 267
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
Annie A. Wu, Virginia E. Drake, Amy Huang, et al.
OncoImmunology (2015) Vol. 4, Iss. 7, pp. e1016700-e1016700
Open Access | Times Cited: 241
The Role of the Mediators of Inflammation in Cancer Development
José Veríssimo Fernandes, Ricardo Ney Cobucci, Carlos André Nunes Jatobá, et al.
Pathology & Oncology Research (2015) Vol. 21, Iss. 3, pp. 527-534
Closed Access | Times Cited: 221
T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
Christina Paluskievicz, Xuefang Cao, Reza Abdi, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 215
Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
Benoı̂t L. Salomon, Mathieu Leclerc, Jimena Tosello, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 164
Recent advances in overcoming barriers to cell‐based delivery systems for cancer immunotherapy
Yingyue Ding, Yixin Wang, Quanyin Hu
Exploration (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 148
Recruitment of monocytes/macrophages in different tumor microenvironments
Heon‐Woo Lee, Hyun-Jung Choi, Sang‐Jun Ha, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2012) Vol. 1835, Iss. 2, pp. 170-179
Closed Access | Times Cited: 199
Roles of IL-8 in Ocular Inflammations: A Review
Hassan Ghasemi, Tooba Ghazanfari, Roya Yaraee, et al.
Ocular Immunology and Inflammation (2011) Vol. 19, Iss. 6, pp. 401-412
Closed Access | Times Cited: 182
OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4+T cells
Andreas Hombach, Johannes Heiders, Marcel Foppe, et al.
OncoImmunology (2012) Vol. 1, Iss. 4, pp. 458-466
Open Access | Times Cited: 178
On the cytokines produced by human neutrophils in tumors
Cristina Tecchio, Patrizia Scapini, Giovanni Pizzolo, et al.
Seminars in Cancer Biology (2013) Vol. 23, Iss. 3, pp. 159-170
Closed Access | Times Cited: 176
Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors
Daniel W. Beury, Katherine H. Parker, Maeva Nyandjo, et al.
Journal of Leukocyte Biology (2014) Vol. 96, Iss. 6, pp. 1109-1118
Open Access | Times Cited: 170
Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites
Powell Perng, Michael Lim
Frontiers in Oncology (2015) Vol. 5
Open Access | Times Cited: 158
Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma
Stefanie R. Dannenmann, Julia Thielicke, Martina Stöckli, et al.
OncoImmunology (2013) Vol. 2, Iss. 3, pp. e23562-e23562
Open Access | Times Cited: 152
Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis
Shuai Zhao, Dang Wu, Pin Wu, et al.
PLoS ONE (2015) Vol. 10, Iss. 10, pp. e0139598-e0139598
Open Access | Times Cited: 151
Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity
Karla R. Wiehagen, Natasha Girgis, Douglas H. Yamada, et al.
Cancer Immunology Research (2017) Vol. 5, Iss. 12, pp. 1109-1121
Open Access | Times Cited: 142
Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients
Hong-Yu Zhang, Ruochen Li, Yifan Cao, et al.
Annals of Surgery (2020) Vol. 275, Iss. 4, pp. e626-e635
Closed Access | Times Cited: 125
The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer.
Jens Geginat, Paola Larghi, Moira Paroni, et al.
Cytokine & Growth Factor Reviews (2016) Vol. 30, pp. 87-93
Closed Access | Times Cited: 124
DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment
Rosanna Villani, Antonio Facciorusso, Francesco Bellanti, et al.
PLoS ONE (2016) Vol. 11, Iss. 12, pp. e0167934-e0167934
Open Access | Times Cited: 118
Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers
Limei Shen, Jingjing Li, Qi Liu, et al.
ACS Nano (2018) Vol. 12, Iss. 10, pp. 9830-9841
Closed Access | Times Cited: 115
Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment
К.-С. Н. Атретханы, Marina S. Drutskaya, Sergei A. Nedospasov, et al.
Pharmacology & Therapeutics (2016) Vol. 168, pp. 98-112
Closed Access | Times Cited: 110
Modulation of tumor microenvironment using a TLR-7/8 agonist-loaded nanoparticle system that exerts low-temperature hyperthermia and immunotherapy for in situ cancer vaccination
Po-Ming Chen, Wen-Yu Pan, Cheng-Yu Wu, et al.
Biomaterials (2019) Vol. 230, pp. 119629-119629
Closed Access | Times Cited: 110
Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer
Lanyun Feng, Qi Qi, Peng Wang, et al.
Journal of International Medical Research (2018) Vol. 46, Iss. 12, pp. 5228-5236
Open Access | Times Cited: 105
Page 1 - Next Page

Scroll to top